Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension

Objective-To investigate whether infusion of adrenomedullin, a potent vasorelaxant peptide, has beneficial haemodynamic and hormonal effects in patients with pulmonary hypertension. Patients and design-The haemodynamic and hormonal responses to intravenous infusion of adrenomedullin (0.05 mug/kg/min) or placebo were examined in 13 patients with precapillary pulmonary hypertension. Results-Infusion of adrenomedullin produced a 44 % increase in cardiac index (mean (SD) 1.8 (0.2) to 2.6 (0.3) 1/min/m(2), p < 0.05) and a 32% decrease in pulmonary vascular resistance (19.7 (1.4) to 13.4 (1.3) units, p < 0.05), with a 4% reduction in mean pulmonary arterial pressure (62 (4) to 59 (4) mm Hg, NS). Adrenomedullin also decreased mean systemic arterial pressure (81 (3) to 72 (4) mm Hg, p < 0.05) and increased heart race (73 (4) to 79 (4) beats/min, p < 0.05). Adrenomedullin decreased plasma aldosterone (9.8 (2.5) to 7.1 (1.5) ng/dl, p < 0.05) without significant changes in plasma renin activity. Plasma atrial and brain natriuretic peptides tended to decrease with adrenomedullin, although these changes did not reach significance. The haemodynamic and hormonal variables remained unchanged during placebo infusion. Conclusions-Intravenous adrenomedullin has beneficial haemodynamic and hormonal effects in patients with precapillary pulmonary hypertension.